skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 123,688  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Journal Title: The Lancet remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
EFFECTS OF HYDROXYCHLOROQUINE AND SULPHASALAZINE ON PROGRESSION OF JOINT DAMAGE IN RHEUMATOID ARTHRITIS
EFFECTS OF HYDROXYCHLOROQUINE AND SULPHASALAZINE ON PROGRESSION OF JOINT DAMAGE IN RHEUMATOID ARTHRITIS
Material Type:
Article 		Add to My Research

EFFECTS OF HYDROXYCHLOROQUINE AND SULPHASALAZINE ON PROGRESSION OF JOINT DAMAGE IN RHEUMATOID ARTHRITIS

The Lancet (British edition), 1989-05, Vol.333 (8646), p.1036-1038 [Peer Reviewed Journal]

1989 ;1990 INIST-CNRS ;Copyright Lancet Ltd. May 13, 1989 ;Copyright Elsevier Limited May 13, 1989 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(89)92442-2 ;PMID: 2565997 ;CODEN: LANCAO

Full text available

Citations Cited by
2
Todd, Hughlings Jackson, and the electrical basis of epilepsy
Todd, Hughlings Jackson, and the electrical basis of epilepsy
Material Type:
Article 		Add to My Research

Todd, Hughlings Jackson, and the electrical basis of epilepsy

The Lancet (British edition), 2001-08, Vol.358 (9281), p.575-577 [Peer Reviewed Journal]

2001 Elsevier Ltd ;2001 INIST-CNRS ;Copyright Lancet Ltd. Aug 18, 2001 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(01)05710-5 ;PMID: 11520547 ;CODEN: LANCAO

Full text available

Citations Cited by
3
Hepatocellular carcinoma
Hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Hepatocellular carcinoma

The Lancet (British edition), 2022-10, Vol.400 (10360), p.1345-1362 [Peer Reviewed Journal]

ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01200-4

Full text available

Citations Cited by
4
Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
Material Type:
Article 		Add to My Research

Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016

The Lancet (British edition), 2017-09 [Peer Reviewed Journal]

info:eu-repo/semantics/openAccess ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)32336-X

Full text available

Citations Cited by
5
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
Material Type:
Article 		Add to My Research

Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

The Lancet (British edition), 2023-03, Vol.401 (10378), p.733-746 [Peer Reviewed Journal]

2023 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)00221-0

Full text available

Citations Cited by
6
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
Material Type:
Article 		Add to My Research

Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK

The Lancet (British edition), 2023-06, Vol.401 (10391), p.1878-1890 [Peer Reviewed Journal]

2023 Elsevier Ltd ;Copyright © 2023 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)00457-9 ;PMID: 37156255

Full text available

Citations Cited by
7
The 2022 report of the Lancet Countdown on health and climate change: health at the mercy of fossil fuels
The 2022 report of the Lancet Countdown on health and climate change: health at the mercy of fossil fuels
Material Type:
Article 		Add to My Research

The 2022 report of the Lancet Countdown on health and climate change: health at the mercy of fossil fuels

The Lancet (British edition), 2022-11, Vol.400 (10363), p.1619-1654 [Peer Reviewed Journal]

2022 Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01540-9 ;PMID: 36306815

Full text available

Citations Cited by
8
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Material Type:
Article 		Add to My Research

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

The Lancet (British edition), 2023-08, Vol.402 (10401), p.529-544 [Peer Reviewed Journal]

2023 Elsevier Ltd ;Copyright © 2023 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)01053-X ;PMID: 37385280

Full text available

Citations Cited by
9
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Material Type:
Article 		Add to My Research

LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial

The Lancet (British edition), 2022-11, Vol.400 (10366), p.1869-1881 [Peer Reviewed Journal]

2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)02033-5

Full text available

Citations Cited by
10
Current best practice for bladder cancer: a narrative review of diagnostics and treatments
Current best practice for bladder cancer: a narrative review of diagnostics and treatments
Material Type:
Article 		Add to My Research

Current best practice for bladder cancer: a narrative review of diagnostics and treatments

The Lancet (British edition), 2022-11, Vol.400 (10364), p.1712-1721 [Peer Reviewed Journal]

2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01188-6

Full text available

Citations Cited by
11
Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial
Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial
Material Type:
Article 		Add to My Research

Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial

The Lancet (British edition), 2022-11, Vol.400 (10363), p.1585-1596 [Peer Reviewed Journal]

2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01882-7

Full text available

Citations Cited by
12
Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017
Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017
Material Type:
Article 		Add to My Research

Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017

The Lancet (British edition), 2018-11 [Peer Reviewed Journal]

cc-by (c) Elsevier B.V., 2018 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/4.0/ ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32278-5

Full text available

Citations Cited by
13
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
Material Type:
Article 		Add to My Research

Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet (British edition), 2023-08, Vol.402 (10403), p.705-719 [Peer Reviewed Journal]

2023 Elsevier Ltd ;Copyright © 2023 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)01185-6 ;PMID: 37385278

Full text available

Citations Cited by
14
The path to healthy ageing in China: a Peking University–Lancet Commission
The path to healthy ageing in China: a Peking University–Lancet Commission
Material Type:
Article 		Add to My Research

The path to healthy ageing in China: a Peking University–Lancet Commission

The Lancet (British edition), 2022-12, Vol.400 (10367), p.1967-2006 [Peer Reviewed Journal]

2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01546-X ;PMID: 36423650

Full text available

Citations Cited by
15
Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial
Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial
Material Type:
Article 		Add to My Research

Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial

The Lancet (British edition), 2023-11, Vol.402 (10414), p.1753-1763 [Peer Reviewed Journal]

2023 Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)02032-9

Full text available

Citations Cited by
16
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants
Material Type:
Article 		Add to My Research

Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants

The Lancet (British edition), 2017, Vol.389 (10064), p.37 [Peer Reviewed Journal]

ISSN: 1474-547X ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31919-5

Full text available

Citations Cited by
17
Benralizumab, an anti-interleukin-5 receptor [alpha] monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
Benralizumab, an anti-interleukin-5 receptor [alpha] monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
Material Type:
Article 		Add to My Research

Benralizumab, an anti-interleukin-5 receptor [alpha] monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

The Lancet (British edition), 2016-10, Vol.388 (10056), p.2128 [Peer Reviewed Journal]

Copyright Elsevier Limited Oct 29, 2016 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31322-8 ;CODEN: LANCAO

Full text available

Citations Cited by
18
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
Material Type:
Article 		Add to My Research

Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial

The Lancet (British edition), 2023-10, Vol.402 (10411), p.1423-1433 [Peer Reviewed Journal]

ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)01245-X

Full text available

Citations Cited by
19
Acute myeloid leukaemia
Acute myeloid leukaemia
Material Type:
Article 		Add to My Research

Acute myeloid leukaemia

The Lancet (British edition), 2023-06, Vol.401 (10393), p.2073-2086 [Peer Reviewed Journal]

2023 Elsevier Ltd ;Copyright © 2023 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)00108-3 ;PMID: 37068505

Full text available

Citations Cited by
20
Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials
Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials
Material Type:
Article 		Add to My Research

Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials

The Lancet (British edition), 2023-10, Vol.402 (10410), p.1338-1346 [Peer Reviewed Journal]

2023 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)01607-0

Full text available

Citations Cited by

Results 1 - 20 of 123,688  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1960  (8,623)
  2. 1960 To 1975  (19,626)
  3. 1976 To 1991  (33,632)
  4. 1992 To 2008  (41,879)
  5. After 2008  (19,998)
  6. More options open sub menu

Resource Type 

  1. Articles  (123,672)
  2. Reviews  (16)
  3. More options open sub menu

Subject 

  1. Life Sciences & Biomedicine  (123,684)
  2. Science & Technology  (123,684)
  3. General & Internal Medicine  (123,678)
  4. Medicine, General & Internal  (123,678)
  5. Humans  (101,223)
  6. Female  (32,495)
  7. Male  (25,054)
  8. Adult  (18,077)
  9. Internal Medicine  (14,334)
  10. Middle Aged  (13,324)
  11. Biological And Medical Sciences  (13,253)
  12. Medical Sciences  (13,062)
  13. Old Medline  (12,423)
  14. Aged  (9,293)
  15. Child  (9,068)
  16. Medical Research  (7,797)
  17. Pregnancy  (7,502)
  18. Adolescent  (7,172)
  19. Animals  (6,480)
  20. United Kingdom  (5,950)
  21. More options open sub menu

Language 

  1. Japanese  (3,949)
  2. Norwegian  (23)
  3. Russian  (20)
  4. French  (3)
  5. Italian  (2)
  6. Portuguese  (1)
  7. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait